Patent details
EP2078026 Title: PRODRUG SALTS OF 2, 4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES.
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- EP2078026
- WO Application Number:
- Type:
- European Patent Granted for NL
- Status:
- Patent in Force
- Publication Title:
- Title When Made Available For Viewing:
- Reason Lapsed:
- Application number:
- EP07864696.5
- WO Publication Number:
- EPO Publication Language:
- English
- SPC Number:
- First Applicant Residence Country:
- United States of America (US)
- Publications:
Dates
- Filing date:
- 20/11/2007
- Grant date:
- 04/01/2012
- EP Publication Date:
- 04/01/2012
- WO Publication Date:
- Claims Translations Received Date:
- Claims Translation B1 Received Date:
- Claims Translation B2 Received Date:
- Claims Translation B3 Received Date:
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Published:
- Due To Cession Date:
- Registration date:
- 04/01/2012
- EP B1 Publication Date:
- 04/01/2012
- EP B2 Publication Date:
- EP B3 Publication Date:
- Description Translation B1 Received Date:
- 03/04/2012
- Description Translation B2 Received Date:
- Description Translation B3 Received Date:
- Expiration date:
- 19/11/2027
- Lapsed By Expiration Date:
- Revocation Date:
- Invalidity Date:
- Response To Novelty Search Report Received:
- Patent Granting Request:
- Lapsed date:
Applicant/holder
- From:
- 04/01/2012
- Name:
- Rigel Pharmaceuticals, Inc.
- Address:
- 1180 Veterans Boulevard, SOUTH SAN FRANCISCO, CA 94080, United States of America (US)
Inventor
1
- Name:
- BHAMIDIPATI, Somasekhar
- Address:
- FOSTER CITY, CALIFORNIA 94404, United States of America (US)
2
- Name:
- SINGH, Rajinder
- Address:
- BELMONT, CALIFORNIA 94002, United States of America (US)
3
- Name:
- SUN, Thomas
- Address:
- FREMONT, CALIFORNIA 94555, United States of America (US)
4
- Name:
- MASUDA, Esteban
- Address:
- MENLO PARK, CALIFORNIA 94025, United States of America (US)
Licensee
- Name:
- AstraZeneca AB
- From:
- 12/04/2012
- Address:
- Västra Mälarehamnen 9, SE-151-85, Södertälje, Sweden (SE)
- To:
Priority
- Priority Patent Number:
- 866722 P
- Priority Date:
- 21/11/2006
- Priority Country:
- United States of America (US)
Classification
- Main IPC Class:
- C07D 498/04;
- IPC or IDT classification:
- A61K 31/5383; A61K 31/675; A61P 37/00; C07F 9/6561;
Publication
Bulletin
1
- Bulletin Heading:
- MED
- Journal edition number:
- 2013/50
- Publication date:
- 11/12/2013
- Description:
- Other communications
2
- Bulletin Heading:
- MED
- Journal edition number:
- 2013/05
- Publication date:
- 30/01/2013
- Description:
- Other communications
3
- Bulletin Heading:
- EP3
- Journal edition number:
- 2012/16
- Publication date:
- 18/04/2012
- Description:
- European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
4
- Bulletin Heading:
- EP2
- Journal edition number:
- 2012/02
- Publication date:
- 11/01/2012
- Description:
- European patents granted for the Netherlands
European Patent Bulletin
- Issue number:
- 201201
- Publication date:
- 04/01/2012
- Description:
- Grant (B1)
Deed
Licence
- Change Kind/ Decision Type:
- Licence termination
- Deed Number:
- 020996-A020996-1
- Date Registered:
- 26/11/2013
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. M.F.J.M. Ketelaars c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Licence
- Change Kind/ Decision Type:
- New licence registration
- Deed Number:
- LRFC-501A
- Date Registered:
- 04/01/2013
- License Effective Date:
- 12/04/2012
- License Expiration Date:
- 26/11/2013
- Scope of License:
- Not Exclusive
- Journal Edition Number:
- Text:
- Beeindiging Licentie door NLO. Zie verder de akte. Expired
- Deed Status:
- Country Code:
- Netherlands (NL)
- Updated License Number:
- Terminated License Number:
Added Licensee(s)
- Name:
- AstraZeneca AB
- Address:
- Västra Mälarehamnen 9, SE-151-85, Södertälje, Sweden (SE)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Licence
- Change Kind/ Decision Type:
- New licence registration
- Deed Number:
- 019020-A019020-1
- Date Registered:
- 04/01/2013
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. M.F.J.M. Ketelaars c.s.
- Journal Edition Number:
- Text:
- Exclusieve licentie ingediend op 4 januari 2013 door Nederlands Octrooibureau te Den Haag. Licentiegever is Rigel Pharmaceuticals, Inc te San Fransisco, Verenigd Staten van Amerika. Zie verder akte.
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Annual Fee
- Annual Fee(s) Due Date:
- 30/11/2025
- Annual Fee Number:
- 19
- Annual Fee Amount:
- 1300 Euro
- Last Annual Payment Date:
- 26/11/2024
- Last Annual Fee Paid Number:
- 18
- Last Annual Fee Paid Amount:
- 1200 Euro
- Payer:
- Computer Packages Inc. (CPI)
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 03/04/2012 | Incoming Correspondence Paper | Other | 1 | /6/9/6/4/6/0507864696/docs/ep07864696.5_0_incomingcorrespondencepaper20120403.pdf | ||
| 03/04/2012 | Claims | Translated claims | 5 | /6/9/6/4/6/0507864696/docs/ep07864696.5_1_claims20120403.pdf |